Further reduction in mortality following myocardial infarction
- PMID: 12422496
- DOI: 10.12968/hosp.2002.63.10.1933
Further reduction in mortality following myocardial infarction
Abstract
Omacor is a new omega-3 fatty acid product that is licensed for secondary prevention post-myocardial infarction. It confers an additional 20% reduction in all-cause mortality, based on the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico prevenzione (GISSI-P) study data. The GISSI-P results are compared with other trials of secondary prevention.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical